- Molecular Markers in Gastric Cancer: Can They Predict Prognosis?
-
Kim SJ, Kim YH
- KMID: 1807214
- Cancer Res Treat.
- 2003 Feb;35(1):1-2.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of More Aggressive Surgery in Esophageal Cancer
-
Park JK, Choi IB
- KMID: 1807221
- Cancer Res Treat.
- 2003 Feb;35(1):52-58.
PURPOSE: One of the most controversial aspects of surgery for esophageal cancer is the appropriate extent of lymphadenectomy to achieve the best outcome. The purpose of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer
-
Yoo CH, Noh SH
- KMID: 1807215
- Cancer Res Treat.
- 2003 Feb;35(1):3-8.
PURPOSE: Alternative splicing of CD44 and aberrant levels of soluble CD44 (sCD44) protein in the serum of cancer patients has been correlated to tumor progression and metastasis. The purpose of... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation between Retinoic Acid Sensitivity and IGFBP-3, AFP Protein Expression in Hepatoma Cell Lines
-
Jung HY, Lee YM, Yoo YD, Kim JS, Park SH, Kim YH
- KMID: 1807222
- Cancer Res Treat.
- 2003 Feb;35(1):59-65.
PURPOSE: Retinoic acid (RA) has been known to inhibit the proliferation, and to induce apoptosis, of various cancer cell lines. We investigated the correlation between the protein levels of the... -
- CITED
-
- Close
- SHARE
-
- Close
- RImmunohistochemical Evaluation of E-cadherin/catenin (alpha-, beta-, gamma-catenin and p120CTN) Complex Expression in Early Gastric Cancer
-
Jo TY, Jeon TY, Chae KH, Kim DH, Sim MS, Park DY, Suh KS
- KMID: 1807217
- Cancer Res Treat.
- 2003 Feb;35(1):16-24.
PURPOSE: The significance of abnormal E-cadherin/ catenin complex expression and the correlation of each of its components in cancer remain unclear. This study aimed to characterize the clinical significance of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Estimation of Breast Cancer Disease-Probability by Difference of Individual Susceptibility
-
Park SK, Yoo KY, Kang DH, Ahn SH, Noh DY, Choe KJ
- KMID: 1807220
- Cancer Res Treat.
- 2003 Feb;35(1):35-51.
PURPOSE: The aims were to evaluate the main risk factors (RFs) of breast cancer and to estimate the individual disease-probability from combinations of RFs in Korean female. MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Experience in Conformal Stereotactic Radiotherapy of Irregularly Shaped Intracranial Tumors
-
Kim KH, Cho MJ, Kim DW, Kim JS, Kim SH, Song CJ, Song SH, Jang JY, Kim JS
- KMID: 1807224
- Cancer Res Treat.
- 2003 Feb;35(1):69-74.
PURPOSE: The dosimetric advantages of multiple non-coplanar stationary fields for stereotactic radiotherapy or adiosurgery (SRT/S) are well known. However, this technique is not widely used due to the logistical problems... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase I and Pharmacokinetic Study of Intraoperative Intraperitoneal Heptaplatin in Patients with Surgically Resected Advanced Gastric Cancer
-
Yu W, Chung HY, Park SH, Cho YB, Lim YS
- KMID: 1807218
- Cancer Res Treat.
- 2003 Feb;35(1):25-29.
PURPOSE: Heptaplatin, a new platinum analog, has favorable toxicity profiles and antitumor activity, comparable to those of cisplatin, in the treatment of gastric cancer. This study was designed to define... -
- CITED
-
- Close
- SHARE
-
- Close
- Overexpression of c-met Protein in Gastric Cancer and Role of uPAR as a Therapeutic Target
-
Oh HA, Lee G, Kang HJ, Kim YG, Bae SH, Lee JL, Lee KH, Hyun MS, Kim DS
- KMID: 1807216
- Cancer Res Treat.
- 2003 Feb;35(1):9-15.
PURPOSE: One of the members of the tyrosine kinase receptor family is the protein product of the c-met proto-oncogene, which is the receptor for hepatocyte growth factor (HGF). HGF is... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy and Safety of DA-3030 (Recombinant Human Granulocyte Colony-Stimulating Factor) in Neutropenia after the Remission Induction Chemotherapy in Patients with Acute Myelogenous Leukemia
-
Min YJ, Suh CW, Park KU, Yoon SS, Park CH, Lee HG
- KMID: 1807223
- Cancer Res Treat.
- 2003 Feb;35(1):66-68.
PURPOSE: This study was conducted to determine the efficacy and safety of DA-3030 (a recombinant methionyl human granulocyte colony-stimulating factor, rhG-CSF), after remission induction chemotherapy, in patients with acute myelogenous... -
- CITED
-
- Close
- SHARE
-
- Close
- A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer
-
Lee SH, Park K, Suh C, Kim HK, Kim JS, Im YH, Kim SW, Heo DS, Bang YJ, Kim NK
- KMID: 1807219
- Cancer Res Treat.
- 2003 Feb;35(1):30-34.
PURPOSE: A combination of paclitaxel and cisplatin is an effective and safe regimen for advanced non-small cell lung cancer (NSCLC). We conducted a multi-center, phase II trial to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Site-Specific Mutagenesis in Escherichia coli by Bulky Exocyclic Amino-Substituted Guanine and Adenine Derivatives in Double-Stranded or Gapped Plasmids
-
Moon KY
- KMID: 1807225
- Cancer Res Treat.
- 2003 Feb;35(1):75-80.
PURPOSE: 7-Bromomethylbenz[alpha]anthracene is a known mutagen and carcinogen. The mutagenic potency of its two major DNA adducts, i.e., N2-(benz[alpha]anthracen-7-ylmethyl)-2'-deoxyguanosine (b[alpha]a2G) and N6-(benz[alpha]anthracen-7-ylmethyl)-2'-deoxyadenosine (b[alpha]a6A), as well as the simpler benzylated analogs,... -
- CITED
-
- Close
- SHARE
-
- Close
